drugset / Trial / NCT05501860
A Safety Study of of AG-920 Sterile Topical Ophthalmic Solution
RandomizedParallel-groupTriple-blindSupportive care
Summary
A Phase 3, randomized, placebo-controlled, double-masked, parallel study in healthy subjects. It is designed to evaluate the ocular safety of a single topical ocular administration of AG-920 sterile topical ophthalmic solution compared to placebo..
Timeline
- Start
- 2022-07-30
- Primary completion
- 2022-12-07
- Completion
- 2022-12-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Articaine | Other / unclassified | — | Topical |
Indications
No indication recorded.